Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04164550 · ClinicalTrials.gov registry record
Interpolated Flap Study
A clinical trial of Mohs Micrographic Surgery and Skin Cancer, Non-Melanoma, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 170
- Enrollment target
- 1
- Study location
NCT04164550: Completed study of Mohs Micrographic Surgery and Skin Cancer, Non-Melanoma, sponsored by University of Pennsylvania.
NCT04164550 is a study of Mohs Micrographic Surgery and Skin Cancer, Non-Melanoma that has completed, run by University of Pennsylvania. The registered enrollment target is 170 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04164550, a study of Mohs Micrographic Surgery and Skin Cancer, Non-Melanoma, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to address the limited knowledge regarding patient well- being and nasal function after interpolated flap repair of post-Mohs surgical defects on the nose. Improved understanding of the patient experience will allow providers to better counsel their patients pre-operatively and potentially identify patients who may benefit from additional interventions.
Primary Outcome
Short term (30 day) complications are defined by the American College of Mohs Surgery as death, bleeding requiring additional intervention, functional loss attributable to surgery, hospitalization for an operative outcome, and surgical site infection.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2018-04-18 |
| Est. Completion | 2020-08-01 |
What the finished NCT04164550 record still lists
NCT04164550 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap.
The record links to 3 conditions, with Mohs Micrographic Surgery appearing as the primary indexed condition, and to 0 interventions.
NCT04164550 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04164550 about?
NCT04164550 is a clinical study titled "Interpolated Flap Study". The primary purpose of this study is to address the limited knowledge regarding patient well- being and nasal function after interpolated flap repair of post-Mohs surgical defects on the nose. Improved understanding of the patient experience will allow providers to better counsel their patients pre-...
What is the current status of trial NCT04164550?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2018-04-18. Estimated completion is 2020-08-01.
What conditions does trial NCT04164550 study?
This clinical trial studies the following conditions: Mohs Micrographic Surgery, Skin Cancer, Non-Melanoma, Skin Cancer Melanoma.
Who is sponsoring clinical trial NCT04164550?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04164550 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mohs Micrographic Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI